In a research report released Friday, Maxim Group analyst Jason Kolbert maintained a Buy rating on Sucampo (NASDAQ:SCMP) with a $15 price target, …
In a research report released today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Sucampo (NASDAQ:SCMP) and raised his price target …
In a research note issued to investors today, Cantor analyst Irina Rivkind assigned a Buy rating on Sucampo (NASDAQ:SCMP) and raised her price target to $14 …
In a report sent to investors today, analyst Ed Arce of Roth Capital maintained a Buy rating on Sucampo (NASDAQ:SCMP) and raised his price target to $18 (from …
In a research report released Wednesday, Roth Capital analyst Ed Arce Affirmed a Buy rating on Sucampo (NASDAQ:SCMP) with a $9 price target, as the company extended its …
In a research note published today, Maxim Group analyst Jason Kolbert upgraded shares of Sucampo Pharmaceuticals (NASDAQ:SCMP) from a Hold rating to a Buy …
In a research report released to investors today, analyst Ed Arce of Roth Capital reiterated a Buy rating on Sucampo (NASDAQ:SCMP) with a $9.00 price …
In a research report issued today, Roth Capital analyst Ed Arce maintained a Buy rating on Sucampo (NASDAQ:SCMP) with a $9 price target, following the company’s …
In a research note released yesterday, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Sucampo Pharmaceuticals (SCMP) with a $12 price target, following the company’s second …
